Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery

The growing significance of messenger RNA (mRNA) therapeutics in diverse medical applications, such as cancer, infectious diseases, and genetic disorders, highlighted the need for efficient and safe delivery systems. Lipid nanoparticles (LNPs) have shown great promise for mRNA delivery, but challeng...

Full description

Bibliographic Details
Main Authors: Xuan Du, Erica Yada, Yuki Terai, Takuya Takahashi, Hideyuki Nakanishi, Hiroki Tanaka, Hidetaka Akita, Keiji Itaka
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/9/2291
_version_ 1797577972840923136
author Xuan Du
Erica Yada
Yuki Terai
Takuya Takahashi
Hideyuki Nakanishi
Hiroki Tanaka
Hidetaka Akita
Keiji Itaka
author_facet Xuan Du
Erica Yada
Yuki Terai
Takuya Takahashi
Hideyuki Nakanishi
Hiroki Tanaka
Hidetaka Akita
Keiji Itaka
author_sort Xuan Du
collection DOAJ
description The growing significance of messenger RNA (mRNA) therapeutics in diverse medical applications, such as cancer, infectious diseases, and genetic disorders, highlighted the need for efficient and safe delivery systems. Lipid nanoparticles (LNPs) have shown great promise for mRNA delivery, but challenges such as toxicity and immunogenicity still remain to be addressed. In this study, we aimed to compare the performance of polyplex nanomicelles, our original cationic polymer-based carrier, and LNPs in various aspects, including delivery efficiency, organ toxicity, muscle damage, immune reaction, and pain. Our results showed that nanomicelles (PEG-PAsp(DET)) and LNPs (SM-102) exhibited distinct characteristics, with the former demonstrating relatively sustained protein production and reduced inflammation, making them suitable for therapeutic purposes. On the other hand, LNPs displayed desirable properties for vaccines, such as rapid mRNA expression and potent immune response. Taken together, these results suggest the different potentials of nanomicelles and LNPs, supporting further optimization of mRNA delivery systems tailored for specific purposes.
first_indexed 2024-03-10T22:15:42Z
format Article
id doaj.art-bbea13e3452e44a6b84880f314df846f
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T22:15:42Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-bbea13e3452e44a6b84880f314df846f2023-11-19T12:27:42ZengMDPI AGPharmaceutics1999-49232023-09-01159229110.3390/pharmaceutics15092291Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA DeliveryXuan Du0Erica Yada1Yuki Terai2Takuya Takahashi3Hideyuki Nakanishi4Hiroki Tanaka5Hidetaka Akita6Keiji Itaka7Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanDepartment of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanDepartment of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanDepartment of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanDepartment of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, JapanGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, JapanDepartment of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo 101-0062, JapanThe growing significance of messenger RNA (mRNA) therapeutics in diverse medical applications, such as cancer, infectious diseases, and genetic disorders, highlighted the need for efficient and safe delivery systems. Lipid nanoparticles (LNPs) have shown great promise for mRNA delivery, but challenges such as toxicity and immunogenicity still remain to be addressed. In this study, we aimed to compare the performance of polyplex nanomicelles, our original cationic polymer-based carrier, and LNPs in various aspects, including delivery efficiency, organ toxicity, muscle damage, immune reaction, and pain. Our results showed that nanomicelles (PEG-PAsp(DET)) and LNPs (SM-102) exhibited distinct characteristics, with the former demonstrating relatively sustained protein production and reduced inflammation, making them suitable for therapeutic purposes. On the other hand, LNPs displayed desirable properties for vaccines, such as rapid mRNA expression and potent immune response. Taken together, these results suggest the different potentials of nanomicelles and LNPs, supporting further optimization of mRNA delivery systems tailored for specific purposes.https://www.mdpi.com/1999-4923/15/9/2291messenger RNA (mRNA)lipid nanoparticle (LNP)polyplex nanomicelle
spellingShingle Xuan Du
Erica Yada
Yuki Terai
Takuya Takahashi
Hideyuki Nakanishi
Hiroki Tanaka
Hidetaka Akita
Keiji Itaka
Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
Pharmaceutics
messenger RNA (mRNA)
lipid nanoparticle (LNP)
polyplex nanomicelle
title Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
title_full Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
title_fullStr Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
title_full_unstemmed Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
title_short Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
title_sort comprehensive evaluation of lipid nanoparticles and polyplex nanomicelles for muscle targeted mrna delivery
topic messenger RNA (mRNA)
lipid nanoparticle (LNP)
polyplex nanomicelle
url https://www.mdpi.com/1999-4923/15/9/2291
work_keys_str_mv AT xuandu comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT ericayada comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT yukiterai comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT takuyatakahashi comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT hideyukinakanishi comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT hirokitanaka comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT hidetakaakita comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery
AT keijiitaka comprehensiveevaluationoflipidnanoparticlesandpolyplexnanomicellesformuscletargetedmrnadelivery